I’m currently involved in a trial for a new cardiac monitoring device and it’s been eye-opening. One major hurdle we’ve faced is ensure the accuracy of data across diverse patient populations. Has anyone else tackled similar issues in their recent studies? Would love to hear your experiences or tips on maintaining protocol integrity.